BiotechTube
Home/Insmed/William H. Lewis
WH

William H. Lewis

Chair and Chief Executive Officer

Insmed

Roles

Chair and Chief Executive OfficeratInsmed
Chairman of the Board of DirectorsatEsperion Therapeutics

Therapeutic Areas

Respiratory DiseasesRare DiseasesPulmonary Arterial HypertensionBronchiectasisInterstitial Lung Disease

Insmed Pipeline

DrugIndicationPhase
Second Approved TherapyRespiratory/Rare DiseaseApproved
ASPEN Study ProgramUndisclosedPhase 3
ARISE Study ProgramUndisclosedPhase 3
PAH ProgramPulmonary Arterial HypertensionPhase 2b
PH-ILD ProgramPulmonary Hypertension Associated with Interstitial Lung DiseasePhase 2a

Leadership Team at Insmed

SM
Sara M. Bonstein
Chief Financial Officer
RA
Roger Adsett
Chief Operating Officer
MF
Martina Flammer
Chief Medical Officer
KM
Kevin Mange
Chief Development Officer
ES
Eugene Sullivan
Chief Product Strategy Officer
MS
Michael Smith
Chief Legal Officer
NS
Nicole Schaeffer
Chief People Strategy Officer
AD
Adele Deering
Senior Vice President, Portfolio Strategy & Operational Excellence
CC
Christie Camelio
Chief Compliance Officer
FG
Fenna Gloggner
Director, Insights – EMEA
View full Insmed profile